Results 71 to 80 of about 3,454 (177)

Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants

Clinical Ophthalmology, 2013
Troels Brynskov,1,2 Caroline Schmidt Laugesen,1 Jakob Halborg,1 Henrik Kemp,1 Torben Lykke Sørensen1,21Department of Ophthalmology, Copenhagen University Hospital Roskilde, Roskilde, Denmark; 2Faculty of Health Sciences, University of Copenhagen ...
Brynskov T, Laugesen CS, Halborg J, Kemp H, Sørensen TL   +4 more
doaj  

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg

Case Reports in Ophthalmology, 2012
We report the case of a 62-year-old woman with a history of vitreoretinal surgery for vitreous hemorrhage secondary to central retinal vein occlusion (CRVO).
Michele Reibaldi, Andrea Russo, Marco Zagari, Mario Toro, Vittorio De Grande, Valentina Cifalinò, Stefania Rametta, Salvatore Faro, Antonio Longo   +8 more
doaj   +1 more source

Safety and efficacy of dexamethasone implant along with phacoemulsification and intraocular lens implantation in children with juvenile idiopathic arthritis associated uveitis

Indian Journal of Ophthalmology, 2019
Purpose: To assess the safety and efficacy of intraoperative intravitreal dexamethasone implant in patients of juvenile idiopathic arthritis (JIA)-associated uveitis undergoing phacoemulsification with posterior chamber intraocular lens (PCIOL ...
Jitender Jinagal, Gaurav Gupta, Aniruddha Agarwal, Kanika Aggarwal, Madhuri Akella, Vishali Gupta, Deepti Suri, Anju Gupta, Surjit Singh, Jagat Ram   +9 more
doaj   +1 more source

Fluocinolone intravitreal implant (Iluvien) for macular edema secondary to immune recovery uveitis in patient with acute myeloid leukemia

Journal of Ophthalmic Inflammation and Infection
Purpose To report the use of Fluocinolone intravitreal implant (Iluvien) for the treatment of persistent cystoid macular edema (CME) due to immune recovery uveitis syndrome in a patient with previous cytomegalovirus retinitis and acute myeloid leukemia ...
JM Cachero Rodríguez, J. Artaraz, Nora Imaz, A. Fonollosa   +3 more
doaj   +1 more source

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

Case Reports in Ophthalmological Medicine, 2017
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion.
Erdem Eris, Gurkan Erdogan, Irfan Perente, Gokhan Demir, Burcin Kepez Yildiz, Ebru Demet Aygit   +5 more
doaj   +1 more source

Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome

Case Reports in Ophthalmology, 2014
Purpose: To evaluate the efficacy of 2 dexamethasone intravitreal implants and 1 ranibizumab intravitreal injection after a bilateral postoperative complication of cataract surgery as pseudophakic cystoid macular edema.
Vito Fenicia, Marco Balestrieri, Andrea Perdicchi, Maurizio Maurizi Enrici, Martina Delle Fave, Santi Maria Recupero   +5 more
doaj   +1 more source

Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber. [PDF]

J Vitreoretin Dis, 2022
Betsch DM, Gupta RR.
europepmc   +1 more source

Cost-Effectiveness of Dexamethasone Intravitreal Implant in Naïve and Previously Treated Patients with Diabetic Macular Edema. [PDF]

Int J Environ Res Public Health, 2023
Medina-Baena M, Cejudo-Corbalán O, Labella-Quesada F, Girela-López E.   +3 more
europepmc   +1 more source

Commentary: Dexamethasone intravitreal implant therapy in Vogt-Koyanagi-Harada disease. [PDF]

Indian J Ophthalmol, 2022
Kawali A, Srinivasan S, Mahendradas P, Shetty R.   +3 more
europepmc   +1 more source

Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats' disease. [PDF]

Arq Bras Oftalmol, 2023
Dorado AM, De-Pablo-Cabrera A, Muñoz-Gallego A, Moreno-García L, Barceló-Mendiguchía A.   +4 more
europepmc   +1 more source